Abstract
Long-term epilepsy-associated tumors (LEATs) constitute a special clinicopathological group of benign brain tumors mainly in temporal and frontal location, which characteristically occur in young age, show a stable course over years, and become symptomatic by a pharmacoresistant epilepsy. Therapeutic goals include both tumor and seizure control. Depending on the relationships between tumor and epileptogenic focus as hypothesized by presurgical workup, different surgical options are available: (1) removal of the tumor only (lesionectomy), (2) removal of the tumor including an intact margin (extended lesionectomy), and (3) tailored resection of the epileptogenic area. With complete removal of the MRI visible tumor (lesionectomy) as the most important prognostic factor, 10-year survival rates of 90% to almost 100% can be achieved. The optimal surgical strategy to achieve seizure control, however, remains controversial. In the absence of robust data from controlled studies only arbitrary recommendations can be given that have proven to be useful in clinical practice. In well delimitable tumors, extended lesionectomy additionally removing an intact margin of 0.5–1.0 cm around the tumor can be recommended providing seizure control in between 70% and 90% of patients. In more diffusely growing tumors infiltrating limbic and/or paralimbic structures, extensive presurgical workup is necessary in order to define the epileptogenic area as well as its functionality and to facilitate an adequate tailored resection.
Tell me and I forget. Teach me and I remember.
Involve me and I learn.
Benjamin Franklin
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blume WT, Girvin JP, Kaufmann JC. Childhood brain tumors presenting as chronic uncontrolled focal cerebral discharges. Ann Neurol. 1989;12:538–41.
Lynam LM, Lyons MK, Drazkowski JF, et al. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg. 2007;109:634–8.
Luyken C, Blümcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, Schramm J. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia. 2003;44:822–30.
Blümcke I, Aronica E, Becker A, et al. Low-grade epilepsy-associated neuroepithelial tumours—the 2016 WHO classification. Nat Rev Neurol. 2016;12:732–40.
Giulioni M, Marucci G, Martinoni M, et al. Epilepsy associated tumors: review article. World J Clin Cases. 2014;2:623–41.
Giulioni M, Martinoni M, Marucci G. Observations on epilepsy associated low-grade tumors and focal cortical dysplasias. Childs Nerv Syst. 2015;31:507–9.
Giulioni M, Martinoni M, Marucci G. Challenges in epilepsy associated tumors. J Neuro-Oncol. 2016;130:239–40.
Pelliccia V, Deleo F, Gozzo F, et al. Early and late epilepsy surgery in focal epilepsies associated with long-term epilepsy-associated tumors. J Neurosurg. 2017;127(5):1147–52.
Aronica E, Gorter JA, Jansen GH, et al. Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol. 2001a;101:449–59.
Aronica E, Leenstra S, van Veelen CW, van Rijen PC, Hulsebos TJ, Tersmette AC, et al. Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery. Epilepsy Res. 2001b;43:179–91.
Blümcke I, Aronica E, Urbach H, Alexopoulos A, Gonzalez-Martinez JA. A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors. Acta Neuropathol. 2014;128:39–54.
Giulioni M, Marucci G, Pelliccia V, Gozzo F, Barba C, et al. Epilepsy surgery of “low grade epilepsy associated neuroepithelial tumors”: a retrospective nationwide Italian study. Epilepsia. 2017;58:1832. https://doi.org/10.1111/epi.13866.
Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of tumours of the central nervous system. Lyon: IARC; 2016.
Prayson R, Fong J, Najm I. Coexistent pathology in chronic epilepsy patients with neoplasms. Mod Pathol. 2010;23:1097–103.
Thom M, Blümcke I, Aronica E. Long-term epilepsy-associated tumors. Brain Pathol. 2012;22:350–79.
Holthausen H, Blümcke I. Epilepsy-associated tumours: what epileptologists should know about neuropathology, terminology, and classification systems. Epileptic Disord. 2016;18:240–51.
Marucci G, Giulioni M. Pathological assessment of epilepsy surgery brain tissue. Pathologica. 2016; 108:80–6.
Boon PA, Williamson PD, Fried I, et al. Intracranial, intraaxial, space-occupying lesions in patients with intractable partial seizures: an anatomicoclinical, neuro-psychological and surgical correlation. Epilepsia. 1991;32:467–76.
De Tisi J, Bell GS, Peacock JL, McEvoy AW, Harkness WF, Sander JW, Duncan JS. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet. 2011;378:1388–95.
Luyken C, Blümcke I, Fimmers R, et al.: Supratentorial gangliogliomas: Histopathological grading and tumor recurrence during a median of eight years in 184 patients. Cancer. 2004; 101, 146–55.
Pasquier B, Péoc’H M, Fabre-Bocquentin B, et al. Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections. Epileptic Disord. 2002;4:99–119.
Prayson RA, Napekoski KM. Composite ganglioglioma/dysembryoplastic neuroepithelial tumor: a clinicopathologic study of 8 cases. Hum Pathol. 2012;43:1113–8.
Bonney PA, Boettcher LB, Conner AK, et al. Review of seizure outcomes after surgical resection of dysembryoplastic neuroepithelial tumors. J Neuro-Oncol. 2016;126:1–10.
Brogna C, Gil Robles S, Duffau H. Brain tumors and epilepsy. Expert Rev Neurother. 2010;8:941–55.
Cossu M, Fuschillo D, Bramerio M, et al. Epilepsy surgery of focal cortical dysplasia-associated tumors. Epilepsia. 2013;54(Suppl. 9):115–22.
Radhakrishnan A, Abraham M, Vilanilam G, et al. Surgery for “long-term epilepsy associated tumors (LEATs)”: seizure outcome and its predictors. Clin Neurol Neurosurg. 2016;141:98–105.
Tomita T, Volk JM, Shen W, et al. Glioneuronal tumors of cerebral hemisphere in children: correlation of surgical resection with seizure outcomes and tumor recurrences. Childs Nerv Syst. 2016;32:1839–48.
Zaghloul KA, Schramm J. Surgical management of glioneural tumors with drug-resistant epilepsy. Acta Neurochir. 2011;153:1551–9.
Kleihues P, Cavanee WK. World Health Organization classification of tumors. Pathology and genetics of tumors of the nervous system. Lyon, France: IARC Press; 2000.
Morris HH, Matkovic Z, Estes ML, Prayson RA, Comair YG, Turnbull J, Najm I, Kotagal P, Wyllie E. Ganglioglioma and intractable epilepsy: clinical and neurophysiologic features and predictors of outcome after surgery. Epilepsia. 1998;39:307–13.
Babini M, Giulioni M, Galassi E, et al. Seizure outcome of surgical treatment of focal epilepsy associated with low-grade tumors in children. J Neurosurg Pediatr. 2013;11:214–23.
Blümcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol. 2002;61:575–84.
Bonney PA, Glenn CA, Ebeling PA, et al. Literature review seizure freedom rates and prognostic indicators after resection of gangliogliomas: a review. World Neurosurg. 2015;84:1988–96.
Chang EF, Christie C, Sullivan JE, Garcia PA, Tihan T, Gupta N, et al. Seizure control outcomes after resection of dysembryoplastic neuroepithelial tumor in 50 patients. J Neurosurg Pediatr. 2010;5:123–30.
Chang EF, Wang DD, Barkovich AJ, Tihan T, Auguste KI, Sullivan JE, et al. Predictors of seizure freedom after surgery for malformations of cortical development. Ann Neurol. 2011;70:151–62.
Ferrier CH, Aronica E, Leijten FSS, Spliet WGM, Van Huffelen AC, Van Rijen PC, Binnie CD. Electrocorticographic discharge patterns in glioneuronal tumors and focal cortical dysplasia. Epilepsia. 2006;47:1477–86.
Giulioni M, Rubboli G, Marucci G, et al. Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneural tumors: lesionectomy compared with tailored resection. J Neuosurg. 2009;111:1275–82.
Giulioni M, Marucci G, Martinoni M, et al. Seizure outcome in surgically treated drug-resistant mesial temporal lobe epilepsy based on the recent histopathological classifications. J Neurosurg. 2013;119:37–47.
Nolan MA, Sakuta R, Chuang N, Otsubo H, Rutka JT, Snead OC III, et al. Dysembryoplastic neuroepithelial tumors in childhood: long-term outcome and prognostic features. Neurology. 2004;62:2270–6.
Sakuta R, Otsubo H, Nolan MA, Weiss SK, Hawkins C, Rutka JT, et al. Recurrent intractable seizures in children with cortical dysplasia adjacent to dysembryoplastic neuroepithelial tumor. J Child Neurol. 2005;20:377–84.
Rudà R, Trevisan E, Soffietti R. Epilepsy and brain tumors. Curr Opin Oncol. 2010;22:611–20.
Samudra N, Zacharias T, Plitt A, et al. Seizures in glioma patients: an overview of incidence, etiology, and therapies. J Neurol Sci. 2019;404:80–5.
Blumcke I, Luyken C, Urbach H, Schramm J, Wiestler OD. An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis. Acta Neuropathol. 2004;107:381–8.
Berger MS, Ghatan S, Haglund MM, Dobbins J, Ojemann GA. Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection. J Neurosurg. 1993;79:62–9.
Hirsch JF, Sainte-Rose C, Kahn PA, et al. Benign astrocytic and oligodendrocytic tumors of the cerebral hemispheres in children. J Neurosurg. 1989;70:568–72.
Spencer DD, Spencer SS, Mattson RH, et al. Intracerebral masses in patients with intractable partial epilepsy. Neurology. 1984;34:432–6.
Olivier A, Boling WW, Tanriverdi T. Epilepsy and brain tumors. In: Olivier A, Boling WW, Tanriverdi T, editors. Techniques in epilepsy surgery. The MNI approach. Cambridge: University Press; 2012. p. 216–33.
Goldring S, Gregory GM. Experience with gliomas and lesions which mimic them in patients presenting with chronic seizure disorders. Part II. Clin Neurosurg. 1986;33:43–70.
Barba C, Coras R, Giordano F, Buccoliero AM, Genitori L, Blümcke I, Guerrini R. Intrinsic epileptogenicity of gangliogliomas may be independent from co-occurring focal cortical dysplasia. Epilepsy Res. 2011;97:208–13.
Rudà R, Bello L, Duffau H, Soffietti R. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro-Oncology. 2012;14:iv55. https://doi.org/10.1093/neuonc/nos199.
Pallud J, McKhann GM. Diffuse low-grade glioma-related epilepsy. Neurosurg Clin N Am. 2019;30(1):43–54.
Rosati A, Tomassini A, Pollo B, et al. Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neuro-Oncol. 2009;93:395–400.
Campbell SL, Robel S, Cuddapah VA, et al. GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy. Glia. 2015;63:23–36.
Van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6:421–30.
Shamij MF, Fric-Shamij EC, Benoit BG. Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg Rev. 2009;32:275–84.
Berntsson SG, Malmer B, Bondy ML, et al. Tumor-associated epilepsy and glioma: are there common genetic pathways? Acta Oncol. 2009;48:955–63.
Marucci G, Giulioni M. Pathological assessment of epilepsy surgery brain tissue. Pathologica. 2016;108:80–6.
Koelsche C, Wöhrer A, Jeibmann A, et al. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Acta Neuropathol. 2013;125:891–900.
Lassaletta A, Zapotocky M, Bouffet E, et al. An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update. Childs Nerv Syst. 2016;32:1789–97.
Marucci G, de Biase D, Visani M, et al. Mutant BRAF in low-grade epilepsy-associated tumors and focal cortical dysplasia. Ann Clin Transl Neurol. 2014;1:130–4.
Chappé C, Padovani L, Scavarda D, et al. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF V600E mutation and expresssion. Brain Pathol. 2013;23:574-83.
Liubinas SV, D’Abaco GM, Moffat BM, et al. IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. Epilepsia. 2014;55:1438–43.
Montes JL, Rosenblatt B, Farmer J-P, et al. Lesionectomy of MRI detected lesions in children with epilepsy. Pediatr Neurosurg. 1995;22:167–73.
Morell F. Secondary epileptogenesis in man. Arch Neurol. 1985;42:318–35.
Rosenow F, Menzler K. Invasive EEG-studies in tumor-related epilepsy: when are they indicated and with what kind of electrodes? Epilepsia. 2013;54(Suppl.9):60–4.
Awad IA, Rosenfeld J, Ahl J, et al. Intractable epilepsy and structural lesions of the brain: mapping, resection strategies, and seizure outcome. Epilepsia. 1991;32:179–86.
Berger MS, Ojemann GA, Lettich E. Neurophysiological monitoring during astrocytoma surgery. Neurosurg Clin North Am. 1990;1:65–80.
Goldring S, Rich KM, Picker S. Experience with gliomas in patients presenting with a chronic seizure disorder. Clin Neurosurg. 1984;33:15.
Englot DJ, Berger MS, Barbaro NM, Chang EF. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia. 2012;53:51–7.
Ramantani G, Kadish NE, Anastasopoulos C, Brandt A, Wagner K, Strobl K, Mayer H, Schubert-Bast S, Stathi A, Korinthenberg R, Feuerstein TJ, Mader I, van Velthoven V, Zentner J, Schulze-Bonhage A. Epilepsy surgery for glioneuronal tumors in childhood: avoid loss of time. Neurosurgery. 2014;74:648–57.
Yang I, Chang EF, Han SJ, et al. Early surgical intervention in adult patients with ganglioglioma in associated with improved clinical seizure outcomes. J Clin Neurosci. 2011;18:29–33.
Bourgeois M, Sainte-Rose C, Lellouch-Tubiana A, et al. Surgery of epilepsy associated with focal lesions in childhood. J Neurosurg. 1999;90:833–42.
Cascino GD, Kelly PJ, Sharbrough FW, Hulihan JF, Hirschorn KA, Trenerry MR. Long-term follow-up of stereotactic lesionectomy in partial epilepsy: predictive factors and electroencephalographic results. Epilepsia. 1992;33:639–44.
Campos AR, Clusmann H, von Lehe M, et al. Simple and complex dysembryoplastic neuroepithelial tumors (DNT) variants: clinical profile, MRI, and histopathology. Neuroradiology. 2009;51:433–43.
Chassoux F, Rodrigo S, Mellerio C, Landré E, Miquel C, Turak B, Laschet J, Meder J-F, Roux F-X, Daumas-Duport C, Devaux B. Dysembryoplastic neuroepithelial tumors. An MRI-based scheme for epilepsy surgery. Neurology. 2012;79:1699–707.
Clusmann H, Kral T, Gleissner U, et al. Analysis of different types of resection for pediatric patients with temporal lobe epilepsy. Neurosurgery. 2004;54:847–60.
Hennessy MJ, Elwes RD, Honavar M, Rabe-Hesketh S, Binnie CD, Polkey CE. Predictors of outcome and pathological considerations in the surgical treatment of intractable epilepsy associated with temporal lobe lesions. J Neurol Neurosurg Psychiatry. 2001;70:450–8.
Raymond AA, Halpin SF, Alsanjari N, et al. Dysembryoplastic neuroepithelial tumor: features in 16 patients. Brain. 1994;117:461–75.
Schulze-Bonhage A, Zentner J. The preoperative investigation and surgical treatment of epilepsy. Deutsch Ärztebl Int. 2014;111:313–9.
Weyerbrock A, Zentner J. Epilepsiechirurgie bei Gliomen. In: Simon M, editor. Glomchirurgie. Heidelberg: Springer; 2018. p. 169–80.
Englot DJ, Berger MS, Barbaro NM, Chang EF. Predictors of seizure freedom after resection of supratentorial low-grade gliomas. J Neurosurg. 2011;115:240–4.
Giulioni M, Gardella E, Rubboli G, et al. Lesionectomy in epileptogenic gangliogliomas: seizure outcome and surgical results. J Clin Neurosci. 2006;13:529–35.
Clusmann H, Schramm J, Kral T, et al. Prognostic factors and outcome after different types of resection for temporal lobe epilepsy. J Neurosurg. 2002;97:1131–41.
Garcia-Fernández M, Fournier-Del CC, Ugalde-Canitrot A, et al. Epilepsy surgery in children with developmental tumors. Seizure. 2011;20;616–27.
Ozlen F, Gunduz A, Asan Z, et al. Dysembryoplastic neuroepithelial tumors and gangliogliomas: clinical results of 52 patients. Acta Neurochir. 2010;152:1661–71.
Rydenhag B, Flink R, Malmgren K. Surgical outcomes in patients with epileptogenic tumours and cavernomas in Sweden: good seizure control but late referrals. J Neurol Neurosurg Psychiatry. 2013;84(1):49–53.
Bilginer B, Yalnizoglu D, Soylemezoglu F, et al. Surgery for epilepsy in children with dysembryoplastic neuroepithelial tumor: clinical spectrum, seizure outcome, neuroradiology, and pathology. Childs Nerv Syst. 2009;25:485–91.
Burneo JG, Tellez-Zenteno J, Steven DA, et al. Adult-onset epilepsy associated with dysembryoplastic neuroepithelial tumors. Seizure. 2008;17:498–504.
Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Neurosurgery. 1988;23:545–56.
Daumas-Duport C, Varlet P, Bacha S, Beuvon F, Cervera-Pierot P, Chodkiewicz JP. Dysembryoplastic neuroepithelial tumors: nonspecific histological forms: a study of 40 cases. J Neuro-Oncol. 1999;41:267–80.
Devaux B, Chassoux F, Guenot M, et al. Epilepsy surgery in France: evaluation of activity. Neurochirurgie. 2008;54:453–65.
Lee J, Lee BL, Joo EY, et al. Dysembryoplastic neuroepithelial tumors in pediatric patients. Brain and Development. 2009;31:671–81.
Sharma MC, Jain D, Gupta A, et al. Dysembryoplastic neuroepithelial tumor: a clinicopathological study of 32 cases. Neurosurg Rev. 2009;32:161–70.
Prayson RA. Diagnostic challenges in the evaluation of chronic epilepsy-related surgical neuropathology. Am J Surg Pathol. 2010;34:e1. https://doi.org/10.1097/PAS.0b013e3181d9ba38.
Takahashi A, Hong SC, Seo DW, Hong SB, Lee M, Suh YL. Frequent association of cortical dysplasia in dysembryoplastic neuroepithelial tumor treated by epilepsy surgery. Surg Neurol. 2005;64:419–27.
Li LM, Cendes F, Andermann F, et al. Surgical outcome in patients with epilepsy and dual pathology. Brain. 1999;122:799–805.
Schramm A, Luyken C, Urbach H, et al. Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy. Neurosurgery. 2004;55:340–8.
Duffau H. Brain mapping in tumors: intraoperative or extra-operative? Epilepsia. 2013;54(Suppl. 9):78–82.
Hirsch M, Coenen VA, Heiland DH, Lützen N, Straszewski O, Schulze-Bonhage A. Epilepsieassoziierte Tumoren des Zentralnervensystems. Nervenarzt. 2015;87:402. https://doi.org/10.1007/s00115-015-0031-7.
Majores M, von Lehe M, Fassunke J, et al. Tumor recurrence and malignant progression of gangliogliomas. Cancer. 2008;113:3355–63.
Harvey AS, Cross JH, Shinnar S, et al. Pediatric epilepsy task force: defining the spectrum of international practice in pediatric epilepsy surgery patients. Epilepsia. 2008;49:146–55.
Cataltepe O, Turanli G, Yalnizoglu D, Topçu M, Akalan N. Surgical management of temporal lobe tumor-related epilepsy in children. J Neurosurg. 2005;102(Suppl 3):280–7.
Gaggero R, Consales A, Fazzini F, Mancardi MM, Baglietto MG, Nozza P, et al. Epilepsy associated with supratentorial brain tumors under 3 years of life. Epilepsy Res. 2009;87:184–9.
Gilliam F, Wyllie E, Kashden J, Faught E, Kotagal P, Bebin M, et al. Epilepsy surgery outcome: comprehensive assessment in children. Neurology. 1997;48:1368–74.
Kim NR, Wang KC, Bang JS, Choe G, Park Y, Kim SK, et al. Glioblastomatous transformation of ganglioglioma: case re- port with reference to molecular genetic and flow cytometric analysis. Pathol Int. 2003;53:874–82.
Ko A, Kim SH, Kim SH, et al. Epilepsy surgery for children with low-grade epilepsy-associated tumors (LEATs): factors associated with seizure recurrence and cognitive function. Pediatr Neurol. 2019;91:50–6.
Ramantani G, Kadish NE, Strobl K, et al. Seizure and cognitive outcomes of epilepsy surgery in infancy and early childhood. Eur J Paediatr Neurol. 2013;17:498–506.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zentner, J. (2020). Long-Term Epilepsy-Associated Tumors (LEATs). In: Surgical Treatment of Epilepsies. Springer, Cham. https://doi.org/10.1007/978-3-030-48748-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-48748-5_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-48747-8
Online ISBN: 978-3-030-48748-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)